KA-PHARMA
Timeline
6 events since 2024Filings
Financial
Establishments
202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 45 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:1005869016
2025
Equity above €150,000 equity €157,474 ▲44.5% With a profit in every financial year since 2024, equity grows to €157,474.
Annual accounts 2024 filed PDFmicro format · 31 days late
2024
IncorporationFounding capital of €3,000, 100 shares · Appointment: KANEZA Aurore-Espérance (director) · published on 13-02-20243 points ▸
- Founding capital, €3,000, 100 shares
- Director appointment, KANEZA Aurore-Espérance (director (not named in the articles))
- Power of attorney, Imad Bazarouji
- The deed holds 2 more points.
First establishment Joseph Baecklaan 74, Molenbeek-Saint-Jean
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 9 February 2024, KA-PHARMA was incorporated as a private limited company by one natural person, with a starting capital of €3,000.12 KANEZA Aurore-Espérance is director of the company, appointed by deed of 13-02-2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3